Phillips AN - Search Results

1

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

Bansi LK, Benzie AA, Phillips AN, Portsmouth S, Hill T, Leen C, Schwenk A, Johnson M, Anderson J, Gilson R, Easterbrook P, Gazzard B, Fisher M, Orkin C, Porter K, Pillay D, Taylor GP, Walsh JC, Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study. Bansi LK, et al. Among authors: phillips an. AIDS. 2008 Jan 30;22(3):349-56. doi: 10.1097/QAD.0b013e3282f4709a. AIDS. 2008. PMID: 18195561

2

Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort.

Phillips A, Lee CA, Elford J, Janossy G, Bofill M, Timms A, Kernoff PB. Phillips A, et al. AIDS. 1989 Nov;3(11):737-41. doi: 10.1097/00002030-198911000-00008. AIDS. 1989. PMID: 2575912

3

CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.

Sabin C, Pasi J, Phillips A, Elford J, Janossy G, Lee C. Sabin C, et al. Thromb Haemost. 1994 Aug;72(2):214-7. Thromb Haemost. 1994. PMID: 7831654

4

The progression of HIV disease in a haemophilic cohort followed for 12 years.

Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. Sabin C, et al. Br J Haematol. 1993 Feb;83(2):330-3. doi: 10.1111/j.1365-2141.1993.tb08290.x. Br J Haematol. 1993. PMID: 8384472

5

CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, Janossy G. Mocroft A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):158-62. doi: 10.1097/00042560-199702010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052725

6

Access to medical care one year prior to diagnosis in 100 HIV-positive women.

Madge S, Olaitan A, Mocroft A, Phillips A, Johnson M. Madge S, et al. Fam Pract. 1997 Jun;14(3):255-7. doi: 10.1093/fampra/14.3.255. Fam Pract. 1997. PMID: 9201502

7

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 Feb 25;13(3):367-73. doi: 10.1097/00002030-199902250-00009. AIDS. 1999. PMID: 10199227

8

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.

Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 May 28;13(8):951-6. doi: 10.1097/00002030-199905280-00011. AIDS. 1999. PMID: 10371176

9

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.

Miller V, Sabin C, Hertogs K, Bloor S, Martinez-Picado J, D'Aquila R, Larder B, Lutz T, Gute P, Weidmann E, Rabenau H, Phillips A, Staszewski S. Miller V, et al. AIDS. 2000 Dec 22;14(18):2857-67. doi: 10.1097/00002030-200012220-00007. AIDS. 2000. PMID: 11153667

10

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

Martínez E, Blanco JL, Arnaiz JA, Pérez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, García-Viejo MA, Mallolas J, Carné X, Phillips A, Gatell JM. Martínez E, et al. AIDS. 2001 Jul 6;15(10):1261-8. doi: 10.1097/00002030-200107060-00007. AIDS. 2001. PMID: 11426070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters